Skip to main content
Top

2018 | OriginalPaper | Hoofdstuk

18. Valt een fase 1-behandeling te combineren met palliatieve zorg?

Auteurs : Johan de Raaf, Karin van der Rijt

Gepubliceerd in: De dokter en de dood

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Enkele maanden geleden werd de 54-jarige mevrouw Mijnders in het ziekenhuis opgenomen omdat zij geel zag.
Literatuur
1.
go back to reference Voogt E, Heide A van der, Rietjens JAC, et al. Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol. 2005;23:2012-2019. Voogt E, Heide A van der, Rietjens JAC, et al. Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol. 2005;23:2012-2019.
2.
go back to reference Mack JW, Weeks JC, Wright AA, et al. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010;28:1203-1208. Mack JW, Weeks JC, Wright AA, et al. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010;28:1203-1208.
3.
go back to reference Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med. 2005;352:895-904. Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med. 2005;352:895-904.
4.
go back to reference Catt S, Langridge C, Fallowfield L, et al. Reasons given by patients for participating, or not, in Phase 1 cancer trials. Eur J Cancer. 2011;47:1490-1497. Catt S, Langridge C, Fallowfield L, et al. Reasons given by patients for participating, or not, in Phase 1 cancer trials. Eur J Cancer. 2011;47:1490-1497.
5.
go back to reference Sulmasy DP, Astrow AB, He MK, et al. The culture of faith and hope: patients’ justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer. 2010;116:3702-3711. Sulmasy DP, Astrow AB, He MK, et al. The culture of faith and hope: patients’ justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer. 2010;116:3702-3711.
6.
go back to reference Nurgat ZA, Craig W, Campbell NC, et al. Patient motivations surrounding participation in phase I and phase ii clinical trials of cancer chemotherapy. Br J Cancer. 2005;92:1001-1005. Nurgat ZA, Craig W, Campbell NC, et al. Patient motivations surrounding participation in phase I and phase ii clinical trials of cancer chemotherapy. Br J Cancer. 2005;92:1001-1005.
7.
8.
go back to reference Hui D, Parsons H, Nguyen L, et al. Timing of palliative care referral and symptom burden in phase 1 cancer patients. A retrospective cohort study. Cancer. 2010;116:4402-4409. Hui D, Parsons H, Nguyen L, et al. Timing of palliative care referral and symptom burden in phase 1 cancer patients. A retrospective cohort study. Cancer. 2010;116:4402-4409.
Metagegevens
Titel
Valt een fase 1-behandeling te combineren met palliatieve zorg?
Auteurs
Johan de Raaf
Karin van der Rijt
Copyright
2018
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2060-8_18